Cardiac Output Monitoring Devices Market Size & Share, by Product (Consumables & Accessories, Devices); Type (Invasive, Non-Invasive); Technology (Pulmonary Artery Catheter, Lithium Dilution Technique); End-user (Hospitals, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4217
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Companies Dominating the Cardiac Output Monitoring Devices Landscape

    • ICU Medical, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Schwarzer Cardiotek GmbH
    • Edwards Lifesciences Corporation
    • Baxter International, Inc.
    • Deltex Medical plc
    • CNSystems Medizintechnik GmbH
    • Abiomed, Inc.
    • Boston Scientific Corporation (BSC)
    • BioTelemetry, Inc.
    • Masimo Corporation


Browse Key Market Insights with Data Illustration:


In The News

  • ICU Medical Inc. acquired Smiths Medical from Smiths Group Plc. In addition to syringes and ambulatory infusion devices, Smith Medical also produces vascular access products and vital care products.

  • Schwarzer Cardiotek GmbH received 510(k) clearance from the US Food and Drug Administration for version 2.2 of its EP-TRACER electronic physiological measurement system, designed to provide a high-quality display of intracardiac ECG signals.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4217
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Worldwide increasing elderly population, rising prevalence of chronic obstructive pulmonary disease (COPD), and an upsurge in surgical procedures are the major factors driving the market growth.

The market is anticipated to attain a CAGR of ~4% over the forecast period, i.e., 2023-2033.

Restricted application of cardiac output monitoring devices, preference for medicines over surgery, and limited insurance coverage options are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are ICU Medical, Inc., Baxter International, Inc., Deltex Medical plc, Boston Scientific Corporation (BSC), BioTelemetry, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, type, technology, end user, and by region

The invasive segment is anticipated to garner t he largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying